3-(Piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
申请人:SUGEN, Inc.
公开号:US20030069421A1
公开(公告)日:2003-04-10
The present invention relates to novel 3-(piperazinyl-benylidenyl)-2-indolinone compounds and derivatives and physiologically acceptable salts thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.
3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the
申请人:Sugen, Inc.
公开号:US05883113A1
公开(公告)日:1999-03-16
The present invention relates to organic molecules apable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal ell proliferation.
3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for
申请人:Sugen, Inc.
公开号:US05886020A1
公开(公告)日:1999-03-23
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.